Trial Profile
A double-blind comparative study of TCSJ-1 for liver resection
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Apr 2018
Price :
$35
*
At a glance
- Drugs Fibrin (Primary)
- Indications Surgical blood loss
- Focus Therapeutic Use
- Sponsors CSL Behring
- 10 Apr 2018 New trial record